References
- Safari S, Movafagh A, Davood ZA, et al. MST1/2 and YAP1 gene expression in acute myeloid leukemia. Leuk Lymphoma 2014;55:2189–2191.
- Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013;13:246–257.
- Chan SW, Lim CJ, Chen L, et al. The Hippo pathway in biological control and cancer development. J Cell Physiol 2011;226:928–939.
- Liu AM, Wong KF, Jiang X, et al. Regulators of mammalian Hippo pathway in cancer. Biochim Biophys Acta 2012;1826:357–364.
- Dong J, Feldmann G, Huang J, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130:1120–1133.
- Overholtzer M, Zhang J, Smolen GA, et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 2006;103:12405–12410.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–408.
- Ren YR, Patel K, Paun BC, et al. Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers. J Biol Chem 2011;286:11960–11969.
- Sudol M, Shields DC, Farooq A. Structures of YAP protein domains reveal promising targets for development of new cancer drugs. Semin Cell Dev Biol 2012;23:827–833.
- Jansson L, Larsson J. Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1. PLoS One 2012;7:e32013.